| |
| |
| Veeda Oncology biostatisticians
have decades of experience in designing and
analyzing oncology studies. Biostatisticians
participate in all aspects of the
clinical trial process. At the protocol
design stage, we can provide support for
scenario analysis in the sample size and power
estimations. Assessments typically include
endpoint differences based upon overall and
progression-free survival, tumor response rates,
and quality of life assessments. Veeda
Oncology biostatisticians can also
communicate with regulatory authorities to
ensure agreement on the analysis strategy; this
dialogue can continue up through market approval
if necessary. Additionally, the biostatistical
staff can assist the computer and regulatory
groups in the preparation of computer assisted
new drug applications (CANDAs), and incorporate
the necessary data tabulations for further
regulatory analysis and graphical displays. |
| |
| Detailed statistical analysis plans are
written that reflect the statistical section of
the protocol. This plan drives the analysis that
is needed for all tables, listings and graphs
required for a study. Statistical analyses are
performed in SASŪ. |
